Li, D., Liu, R., Fu, Z., Yang, F., Ma, L., Cao, M., Guo, Y., Deng, B., Zhang, A. H., Zheng, Q., Ke, X., Hu, K. (2025). Prospective phase I/II study of CD19-directed CAR-t therapy in relapsed/refractory central nervous system lymphoma: Clinical outcomes and safety profile. Blood. https://doi.org/10.1182/blood-2025-672